Bexagliflozin

Clinical Pharmacology Update| October 26 2023 Bexagliflozin Megan Giruzzi; Megan Giruzzi 1Washington State University, College of Pharmacy and Pharmaceutical Sciences, Spokane, WA Corresponding author: Megan Giruzzi, megan.giruzzi@wsu.edu Search for other works by this author on: This Site PubMed Google Scholar Ashley Worthey Ashley Worthey 2MultiCare Yakima Memorial Hospital, Yakima, WA Search for other works by this author on: This Site PubMed Google Scholar Corresponding author: Megan Giruzzi, megan.giruzzi@wsu.edu Clin Diabetes cd230085 https://doi.org/10.2337/cd23-0085 Views Icon Views Article contents Figures & tables Video Audio Supplementary Data Peer Review Share Icon Share Facebook Twitter LinkedIn Email Cite Icon Cite Get Permissions Citation Megan Giruzzi, Ashley Worthey; Bexagliflozin. Clin Diabetes 2023; cd230085. https://doi.org/10.2337/cd23-0085 Download citation file: Ris (Zotero) Reference Manager EasyBib Bookends Mendeley Papers EndNote RefWorks BibTex toolbar search Search Dropdown Menu toolbar search search input Search input auto suggest filter your search All ContentAll JournalsClinical Diabetes Search Advanced Search This content is only available via PDF. ©2023 by the American Diabetes Association2023Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at https://www.diabetesjournals.org/journals/pages/license. Article PDF first page preview Close Modal You do not currently have access to this content.